Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,681 | 86,573 | 95,502 | 106,080 | 112,381 |
| TOTAL | $83,723 | $87,964 | $97,709 | $108,910 | $114,821 |
| Non-Current Assets | |||||
| PPE Net | 20,180 | 20,403 | 20,646 | 20,823 | 20,563 |
| TOTAL | $20,180 | $20,403 | $20,646 | $20,823 | $20,563 |
| Total Assets | $103,903 | $108,367 | $118,355 | $129,733 | $135,384 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,291 | 39,189 | 41,647 | 46,092 | 42,822 |
| Accrued Expenses | 746 | 851 | 1,989 | 1,728 | 4,351 |
| Other current liabilities | 121 | 75 | 198 | 226 | N/A |
| TOTAL | $40,158 | $40,115 | $43,834 | $48,046 | $47,332 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 136 | 111 | 118 | 119 | 79 |
| TOTAL | $136 | $111 | $118 | $119 | $79 |
| Total Liabilities | $40,294 | $40,226 | $43,952 | $48,165 | $47,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,308 | 48,308 | 48,308 | 48,308 | 48,308 |
| Common Shares | 48 | 48 | 48 | 48 | 48 |
| Retained earnings | -515,018 | -506,415 | -496,084 | -483,545 | -472,738 |
| TOTAL | $63,609 | $68,141 | $74,403 | $81,568 | $87,973 |
| Total Liabilities And Equity | $103,903 | $108,367 | $118,355 | $129,733 | $135,384 |